Im a biomedical researcher passionate about advancing cancer immunotherapy through engineered NK cell therapies. At MD Anderson Cancer Center, I studies how the tumor microenvironment shapes immune cell behavior, using cutting-edge single-cell and spatial technologies. My work focuses on overcoming barriers that prevent NK cells from effectively infiltrating and persisting in solid tumors, with the goal of designing smarter, more durable cell therapies. I am particularly interested in bridging computational biology with clinical translation, ensuring that discoveries in the lab directly inform patient care. Driven by both scientific curiosity and clinical impact, Im committed to developing innovative immunotherapy strategies that expand treatment options and improve outcomes for cancer patients.